ABSTRACT Objectives To establish how celecoxib use after tonsillectomy and adenoidectomy (T 34% male; 55% Caucasian. The celecoxib cohort ( N = 38) consumed an average of 66.2 mL (SD = 62.1) of opioids, and the non‐celecoxib cohort ( N = 42) received an average of 118.4 mL (SD = 91.6) ( p = 0.021). There were no significant differences in pain scores reported on POD 1, 5, or 10 ( p = 0.5, p = 0.2, p = 0.6, respectively). Conclusion The addition of postoperative celecoxib resulted in a significant decrease in mean opioid consumption. Our data also demonstrate that postoperative pain was controlled similarly based on patient reported pain scores, regardless of celecoxib consumption. Further investigation is warranted with larger sample sizes to determine the efficacy of postoperative celecoxib use. Level of Evidence 3.
Platukus et al. (Sun,) studied this question.